Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2012, Vol. 32 Issue (6): 125-130    
专题     
十一五国家高技术研究发展计划“重大疾病的分子分型和个体化诊疗”重大项目布局及实施情况分析
于振行, 王德平
中国生物技术发展中心 北京 100039
Analysis of Molecular Diagnostics and Individuation Treatment Aiming at Serious Diseases Topics in "Eleventh Five-Year Plan" National High Technology Research and Development Program
YU Zhen-hang, WANG De-ping
China National Center for Biotechnology Development, Beijing 100039, China
 全文: PDF(542 KB)   HTML
摘要:

简要分析了"十一五"期间国家高技术研究发展计划("863"计划)"重大疾病的分子分型和个体化诊疗"重大项目的课题设置及实施情况。分别从本项目研究方向及课题设置、课题承担单位及研究人员结构、课题完成情况及所取得的代表性研究成果等方面进行了具体分析和归纳总结,供广大科技工作者参考。

关键词: "863"计划分子分型个体化诊疗重大疾病    
Abstract:

A brief analysis about National High Technology Research and Development Program(863)molecular diagnostics and individuation treatment aiming at serious diseases topics in "Eleventh Five-Year Plan" was given. The details about topics plan, institutions carrying out the topics and representative research results were presented,maybe these informations are useful to scientific and technical workers.

Key words: National High Technology Research and Development Program    Molecular diagnostics    Individuation treatment    Serious diseases
收稿日期: 2012-04-09 出版日期: 2012-06-25
ZTFLH:  Q819  
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
于振行
王德平

引用本文:

于振行, 王德平. 十一五国家高技术研究发展计划“重大疾病的分子分型和个体化诊疗”重大项目布局及实施情况分析[J]. 中国生物工程杂志, 2012, 32(6): 125-130.

YU Zhen-hang, WANG De-ping. Analysis of Molecular Diagnostics and Individuation Treatment Aiming at Serious Diseases Topics in "Eleventh Five-Year Plan" National High Technology Research and Development Program. China Biotechnology, 2012, 32(6): 125-130.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I6/125

[1] Duan X, Yue W, Liu L, et al. Single-nucleotide polymorphism (SNP) genotyping using cationic conjugated polymers in homogeneous solution. Nat Protoc, 2009, 4(6): 984-991.
[2] Li D D, Wang L L, Deng R, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene, 2009, 28(6):886-898.
[3] Huang P Y, Hong M H, Zhang X, et al. C-KIT overexpression and mutation in nasopharyngeal carcinoma cell lines and reactivity of Imatinib on these cell lines. Chin J Cancer, 2010,29(2):131-135.
[4] Fu J F, Shi J Y, Zhao W L, et al. MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders. Leukemia, 2008, 22(3):660-663.
[5] 于颖彦, 吕有勇. 胃癌病理分型和诊断标准的建议.中华病理学杂志, 2010, 39:266-269. Yu Y Y, Lv Y Y. Advice on molecular diagnostics and individuation treatment of gastric cancer. Chin J Pathol, 2010, 39:266-269.
[6] Hao Y, Yu Y, Wang L, et al. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J Proteome Res, 2008, 7(9):3668-3677.
[7] Yang Y H, Deng H, Li W M, et al. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling. Clin Cancer Res, 2008, 14(1):74-81.
[8] Xu X, Li W, Fan X, et al. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene, 2007, 26(52):7371-7379.
[9] Zhang X W, Yan X J, Zhou Z R, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science, 2010, 328(5975):240-243.

[1] 贾小梅,倪莉,罗洪艳,丁红雷,王豪举. 猪多杀性巴氏杆菌检测技术研究进展 *[J]. 中国生物工程杂志, 2020, 40(8): 49-54.
[2] 张玲梅,王豪举. 猪链球菌检测技术研究进展 *[J]. 中国生物工程杂志, 2020, 40(4): 84-91.
[3] 艾瑞婷, 王德平. 十一五863计划"针对重大疾病的药物分子设计及产品开发"重点项目课题布局及实施情况分析[J]. 中国生物工程杂志, 2012, 32(04): 123-127.
[4] 艾瑞婷, 王德平. "十一五"863计划"基于功能基因组和结构基因组的药物分子设计"重点项目课题布局及实施情况分析[J]. 中国生物工程杂志, 2012, 32(01): 124-128.